Stock Alert: Reata Pharmaceuticals Tanks 30% As Rare Genetic Disease Drug In Limbo

Shares of Reata Pharmaceuticals Inc. (RETA) tanked nearly 30% on Monday morning after the drug maker's Omaveloxoloneon, a drug being developed to treat a rare neurodegenerative disorder, hit a roadblock.

from RTT - Earnings https://ift.tt/33HdxVL
via IFTTT